Free Trial

Autoscope Technologies (AATC) Competitors

Autoscope Technologies logo
$7.50 +0.09 (+1.18%)
As of 07/2/2025 02:43 PM Eastern

AATC vs. RPID, OWLT, SEER, PRE, NAUT, INTT, OPXS, ODYS, AKYA, and OMIC

Should you be buying Autoscope Technologies stock or one of its competitors? The main competitors of Autoscope Technologies include Rapid Micro Biosystems (RPID), Owlet (OWLT), Seer (SEER), Prenetics Global (PRE), Nautilus Biotechnology (NAUT), inTEST (INTT), Optex Systems (OPXS), Odysight.ai (ODYS), Akoya Biosciences (AKYA), and Singular Genomics Systems (OMIC). These companies are all part of the "measuring and control equipment" industry.

Autoscope Technologies vs. Its Competitors

Autoscope Technologies (NASDAQ:AATC) and Rapid Micro Biosystems (NASDAQ:RPID) are both small-cap measuring and control equipment companies, but which is the better business? We will contrast the two companies based on the strength of their valuation, profitability, risk, media sentiment, analyst recommendations, dividends, earnings and institutional ownership.

52.6% of Rapid Micro Biosystems shares are held by institutional investors. 21.6% of Autoscope Technologies shares are held by insiders. Comparatively, 30.0% of Rapid Micro Biosystems shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

Autoscope Technologies has higher earnings, but lower revenue than Rapid Micro Biosystems. Rapid Micro Biosystems is trading at a lower price-to-earnings ratio than Autoscope Technologies, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Autoscope Technologies$12.89M3.19$6.62M$0.7310.27
Rapid Micro Biosystems$28.05M5.78-$46.89M-$1.03-3.59

Rapid Micro Biosystems has a consensus price target of $8.00, indicating a potential upside of 116.22%. Given Rapid Micro Biosystems' stronger consensus rating and higher possible upside, analysts clearly believe Rapid Micro Biosystems is more favorable than Autoscope Technologies.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Autoscope Technologies
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00
Rapid Micro Biosystems
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
1 Strong Buy rating(s)
4.00

Autoscope Technologies has a beta of 0.63, suggesting that its stock price is 37% less volatile than the S&P 500. Comparatively, Rapid Micro Biosystems has a beta of 1.32, suggesting that its stock price is 32% more volatile than the S&P 500.

In the previous week, Rapid Micro Biosystems had 1 more articles in the media than Autoscope Technologies. MarketBeat recorded 1 mentions for Rapid Micro Biosystems and 0 mentions for Autoscope Technologies. Autoscope Technologies' average media sentiment score of 0.00 equaled Rapid Micro Biosystems'average media sentiment score.

Company Overall Sentiment
Autoscope Technologies Neutral
Rapid Micro Biosystems Neutral

Autoscope Technologies has a net margin of 37.59% compared to Rapid Micro Biosystems' net margin of -151.22%. Autoscope Technologies' return on equity of 27.06% beat Rapid Micro Biosystems' return on equity.

Company Net Margins Return on Equity Return on Assets
Autoscope Technologies37.59% 27.06% 23.97%
Rapid Micro Biosystems -151.22%-56.07%-44.11%

Summary

Rapid Micro Biosystems beats Autoscope Technologies on 9 of the 15 factors compared between the two stocks.

Get Autoscope Technologies News Delivered to You Automatically

Sign up to receive the latest news and ratings for AATC and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding AATC and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

AATC vs. The Competition

MetricAutoscope TechnologiesMeasuring & controlling devices IndustryBusiness SectorNASDAQ Exchange
Market Cap$41.18M$35.61M$13.13B$9.05B
Dividend Yield8.09%8.09%2.54%4.03%
P/E Ratio8.524.2628.7920.21
Price / Sales3.193.4341.14118.64
Price / Cash8.388.3826.6558.07
Price / Book1.821.826.285.67
Net Income$6.62M$7.16M$188.91M$249.13M
7 Day Performance4.17%3.99%3.62%3.30%
1 Month Performance-1.32%16.37%4.21%5.20%
1 Year Performance18.11%11.87%28.02%21.38%

Autoscope Technologies Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
AATC
Autoscope Technologies
N/A$7.50
+1.2%
N/A+18.1%$41.18M$12.89M8.5240
RPID
Rapid Micro Biosystems
1.5051 of 5 stars
$3.49
+1.2%
$8.00
+129.2%
+513.6%$152.97M$28.05M-3.39200News Coverage
Positive News
OWLT
Owlet
0.8316 of 5 stars
$8.33
-0.8%
$7.75
-7.0%
+112.2%$137.63M$78.10M-5.83106High Trading Volume
SEER
Seer
2.1482 of 5 stars
$2.19
+2.3%
$3.00
+37.0%
+36.6%$128.93M$14.17M-1.55160News Coverage
PRE
Prenetics Global
1.675 of 5 stars
$8.28
-2.8%
$9.00
+8.7%
+38.1%$101.02M$30.62M-2.081
NAUT
Nautilus Biotechnology
2.4898 of 5 stars
$0.73
+0.7%
$2.13
+191.1%
-63.8%$92.09MN/A-1.35130High Trading Volume
INTT
inTEST
3.0132 of 5 stars
$7.26
-0.3%
$12.00
+65.3%
-33.3%$90.71M$127.50M31.57320
OPXS
Optex Systems
1.825 of 5 stars
$11.74
+2.2%
N/A+69.8%$81.12M$33.99M16.5480
ODYS
Odysight.ai
1.2547 of 5 stars
$4.95
-2.9%
$10.00
+102.0%
N/A$80.76M$5.84M-4.8540News Coverage
Gap Down
AKYA
Akoya Biosciences
2.1696 of 5 stars
$1.32
+1.5%
$2.51
+89.8%
-35.7%$65.93M$81.67M-1.3690
OMIC
Singular Genomics Systems
0.4024 of 5 stars
$20.01
flat
$6.50
-67.5%
N/A$50.83M$2.91M-0.57220

Related Companies and Tools


This page (NASDAQ:AATC) was last updated on 7/4/2025 by MarketBeat.com Staff
From Our Partners